loader image
CURE Pharmaceutical Completes $20 Million Acq…

– Acquisition to Support Cash Flow Positive Goal in ~18 Months – CURE Pharmaceutical Holdings (OTC: CURR) today announced its definitive agreement to acquire Sera Labs, Inc. The closing is anticipated to occur in early October. As previously announced, the…

CURE Pharmaceutical to Present at Two Virtual…

– CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT –  – CURE CEO will be a panelist at the 4@4 Forum on September 10 @4pm PDT – OXNARD, Calif., Sept. 02, 2020 (GLOBE…

CURE Pharmaceutical to Acquire Sera Labs, a L…

CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction U.S. markets close in 1 hour 53 minutes S&P 500 3,241.33 +1.92 (+0.06%)   Dow 30…

CURE Pharmaceutical CBD Oral Thin Film Pharma…

Significantly higher serum concentration and absorption Showcases CUREform™ encapsulation and oral thin film technology OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD)…

CURE Pharmaceutical Receives NSF’s cGMP Certi…

OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing facility has earned NSF International, cGMP certification for the manufacture of dietary supplements. This…

CURE Pharmaceutical Appoints Chief Business O…

– Jonathan Berlent Appointed to Newly Created Role – OXNARD, Calif., June 16, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Jonathan Berlent, 51, to the newly created position of Chief Business…

CURE Pharmaceutical Announces Exercise of War…

OXNARD, Calif., June 09, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical Holding Corp. (CURR), an innovative drug delivery company that is developing novel ways to deliver active ingredients, announced today that it strengthened its balance sheet with the receipt of $1.4…

CURE Pharmaceutical Expands to Mexico in Coll…

CURE extends vitamin D, sleep and combination CBD products distribution throughout Mexico OXNARD, Calif., June 03, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, announced today a collaboration with PMI, a subsidiary of Factoria…

CURE Pharmaceutical Expands Cannabis Extracti…

Equipment manufacturers, cannabis processors and drug developers can license CURE’s patented methods for optimal extraction of cannabinoids LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the issuance of…

CURE Pharmaceutical Secures Chinese Patent on…

ED Drug Market Expected to Reach US$6.5B by 2025 OXNARD, Calif., March 17, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No. ZL201480039313.6. The new patent covers…